Back to
UBS Group AG
SNDX30 quarters
Position history for
UBS Group AG's holdings in SYNDAX PHARMACEUTICALS INC
UBS Group AG holds 1.9M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $41.4M as of 2026-Q2. The position was increased (+64.2% shares). SNDX represents 0.0% of UBS Group AG's portfolio.
Current Value
$41.4M
Current Shares
1.9M
Total Value Change
+$41.4M
Total Shares Change
+1.9M
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.